BNGO · Bionano Genomics, Inc. · Held by Funds
$1.45
-0.12 (-7.64%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has prepared cash flows forecasts which indicate that based on the Company’s expected operating losses and negative cash flows, there is substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the six months ended June 30, 2026, are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$20.37M
Shares
11.78M
Volume · Oct 2
383.96K
Avg daily vol (3M)
912.38K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BNGO
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Cabot Growth ETF | — | 116,092 | $453,920 | 1.78% | Long | 2021-11-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 113,564 | $140,819 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 82,388 | $93,098 | 0.00% | Long | 2026-06-30 | |
| Direxion Nanotechnology ETF | — | 43,973 | $79,591 | 6.04% | Long | 2023-01-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 11,470 | $14,223 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 2,769 | $3,434 | 0.00% | Long | 2026-05-31 |
Showing 1–6 of 6 positions